Log In
Print
BCIQ
Print
Print this Print this
 

Lonquex, lipegfilgrastim (XM22)

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionGlyco-pegylated recombinant human granulocyte colony-stimulating factor (G-CSF; CSF3)
Molecular Target Granulocyte colony-stimulating factor (G-CSF) (CSF3)
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationNeutropenia
Indication DetailsPrevent chemotherapy-induced neutropenia; Treat aggressive B cell Non-Hodkins lymphomas at high risk for R-Chop-21 induced neutropeina
Regulatory Designation EU - Standard Review (Prevent chemotherapy-induced neutropenia)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today